Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children

被引:71
作者
Kuhn, L
Steketee, RW
Weedon, J
Abrams, EJ
Lambert, G
Bamji, M
Schoenbaum, E
Farley, J
Nesheim, SR
Palumbo, P
Simonds, RJ
Thea, DM
机构
[1] Columbia Univ, Gertrude H Sergievsky Ctr, Med & Hlth Res Assoc Inc, Harlem Hosp Ctr, New York, NY 10032 USA
[2] Metropolitan Hosp Ctr, New York, NY 10029 USA
[3] Lebanon Hosp, Bronx, NY USA
[4] Montifore Hosp, Bronx, NY USA
[5] Emory Univ, Atlanta, GA 30322 USA
[6] Ctr Dis Control & Prevent, Atlanta, GA USA
[7] Univ Maryland, Baltimore, MD 21201 USA
[8] Univ Med & Dent New Jersey, Newark, NJ 07103 USA
关键词
D O I
10.1086/314551
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Predictors and prognosis of intrauterine and intrapartum human immunodeficiency virus (HIV) transmission were investigated among 432 children of HIV-infected women in the Perinatal AIDS Collaborative Transmission Study. Timing of transmission was inferred from polymerase chain reaction or viral culture within 2 days of birth, Proportions of infections due to intrauterine transmission were similar among women using (29%) or not using zidovudine (30%). Preterm delivery was strongly associated with intrapartum transmission (relative risk, 3.7; 95% confidence interval [CI], 2.2-6.1), particularly among infants delivered longer after membrane rupture, but was not associated with intrauterine transmission, Progression to AIDS or death increased 2.5-fold (95% CI, 1.1-5.8) among intrauterine infected children, adjusting for preterm delivery, and maternal CD4 cell count, Early transmission appears unlikely to explain instances of zidovudine failure. Preterm infants may be more vulnerable to HIV acquisition at delivery, especially if membrane rupture is prolonged. Intrauterine infection does not appear to increase risk of preterm delivery.
引用
收藏
页码:52 / 58
页数:7
相关论文
共 32 条
[1]   Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants [J].
Abrams, EJ ;
Weedon, J ;
Steketee, RW ;
Lambert, G ;
Bamji, M ;
Brown, T ;
Kalish, ML ;
Schoenbaum, EE ;
Thomas, PA ;
Thea, DM .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (01) :101-108
[2]  
ABRAMS EJ, 1995, PEDIATRICS, V96, P451
[3]   Perinatal intervention trial in Africa: Effect of a birth canal cleansing intervention to prevent HIV transmission [J].
Biggar, RJ ;
Miotti, PG ;
Taha, TE ;
Mtimavalye, L ;
Broadhead, R ;
Justesen, A ;
Yellin, F ;
Liomba, G ;
Miley, W ;
Waters, D ;
Chiphangwi, D ;
Goedert, JJ .
LANCET, 1996, 347 (9016) :1647-1650
[4]   RELATION OF THE COURSE OF HIV-INFECTION IN CHILDREN TO THE SEVERITY OF THE DISEASE IN THEIR MOTHERS AT DELIVERY [J].
BLANCHE, S ;
MAYAUX, MJ ;
ROUZIOUX, C ;
TEGLAS, JP ;
FIRTION, G ;
MONPOUX, F ;
CIRARUVIGNERON, N ;
MEIER, F ;
TRICOIRE, J ;
COURPOTIN, C ;
VILMER, E ;
GRISCELLI, C ;
DELFRAISSY, JF ;
TARDIEU, M ;
NOSEDA, G ;
HURAUX, JM ;
LEVINE, M ;
VILMER, E ;
DECREPY, A ;
SIMON, F ;
KRIVINE, A ;
FRANCOUAL, C ;
DIMARIA, L ;
COURPOTIN, C ;
MONCOMBLE, CC ;
BURGARD, M ;
ROUZIOUX, C ;
GIRAULT, D ;
STEPHAN, JL ;
BLANCHE, S ;
TERRIS, J ;
VEBER, F ;
FIRTION, G ;
HENRION, R ;
CIRARUVIGNERON, N ;
BRUNER, C ;
MATHIEU, FP ;
HERVE, F ;
ALLISY, C ;
DANDINE, M ;
LABRUNE, P ;
VIAL, M ;
LACHASSINE, E ;
GAUDELUS, J ;
FLOCH, C ;
MAZY, F ;
MEIER, F ;
ROBIN, M ;
ALLEMON, MC ;
TALON, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (05) :308-312
[5]  
BRYSON YJ, 1992, NEW ENGL J MED, V327, P1246, DOI 10.1056/NEJM199210223271718
[6]   THE USE OF VIRAL CULTURE AND P24-ANTIGEN TESTING TO DIAGNOSE HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN NEONATES [J].
BURGARD, M ;
MAYAUX, MJ ;
BLANCHE, S ;
FERRONI, A ;
GUIHARDMOSCATO, ML ;
ALLEMON, MC ;
CIRARUVIGNERON, N ;
FIRTION, G ;
FLOCH, C ;
GUILLOT, F ;
LACHASSINE, E ;
VIAL, M ;
GRISCELLI, C ;
ROUZIOUX, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (17) :1192-1197
[7]  
Caldwell MB, 1994, MMWR-MORBID MORTAL W, V4, P1
[8]   Timing of mother-to-child HIV-1 transmission and diagnosis of infection based on polymerase chain reaction in the neonatal period by a non-parametric method [J].
Chouquet, C ;
Burgard, M ;
Richardson, S ;
Rouzioux, C ;
Costagliola, D .
AIDS, 1997, 11 (09) :1183-1184
[9]   IDENTIFYING HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AT BIRTH - APPLICATION OF POLYMERASE CHAIN-REACTION TO GUTHRIE CARDS [J].
COMEAU, AM ;
HSU, HW ;
SCHWERZLER, M ;
MUSHINSKY, G ;
WALTER, E ;
HOFMAN, L ;
GRADY, GF .
JOURNAL OF PEDIATRICS, 1993, 123 (02) :252-258
[10]   REPLICATION AND TROPISM OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AS PREDICTORS OF DISEASE OUTCOME IN INFANTS WITH VERTICALLY ACQUIRED INFECTION [J].
DEROSSI, A ;
GIAQUINTO, C ;
OMETTO, L ;
MAMMANO, F ;
ZANOTTO, C ;
DUNN, D ;
CHIECOBIANCHI, L .
JOURNAL OF PEDIATRICS, 1993, 123 (06) :929-936